A Comparative Study of Monopolar Versus Bipolar Electrocautery Post Tonsillectomy Outcomes. (CSMVBET)

November 24, 2025 updated by: Dr. Dureshahwar Bhurgri, Indus Hospital and Health Network
This study aims to compare surgical techniques (monopolar and bipolar electrocautery -used during tonsillectomy,a common procedure to remove toonsils.The goal is to determine which method results in less pain and bleeding for patients after surgery .

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

To evaluate and compare post operative pain and bleeding outcomesbetween monopolar and bipolar electrocautery technique used dutring tonsillectomy .

Methodology : Total 112 patients were randomly divided into two groups (56 each groups ).Pain was assessed postoperatively and classified as mild ,moderate or severe .

Study Type

Observational

Enrollment (Estimated)

74

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sindh
      • Karachi, Sindh, Pakistan, 75500
        • Indus Hospital Karachi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The frequent patients are children

Description

Inclusion Criteria

  • Patients aged between 5 and 40 years.
  • Indicated for elective tonsillectomy due to recurrent tonsillitis, obstructive sleep apnea, or chronic tonsillar hypertrophy.
  • Medically stable to undergo general anesthesia and surgical procedure.
  • Ability to understand and provide informed consent (or parental/guardian consent for minors).
  • Willing to complyy with study procedures and follow-up schedule. Exclusion Criteria
  • History of bleeding disorders (e.g., hemophilia, thrombocytopenia).
  • Use of anticoagulants or antiplatelet therapy within 7 days prior to surgery.
  • Known allergy or adverse reaction to anesthesia agents used in the procedure.
  • Previous tonsillar surgery or peritonsillar abscess drainage.
  • Severe comorbidities that may interfere with surgery or recovery (e.g., uncontrolled diabetes, heart failure).
  • Patients with craniofacial abnormalities affecting the airway.
  • Inability to understand or comply with study requirements.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post operative pain and bleeding in patient undergone tonsillectomy
Time Frame: 24 hours after surgery and beyond 24 hours

Postoperative Bleeding: Occurrence of postoperative reactionary and secondary bleeding

Reactionary bleeding: If bleeding occurs within the first 24 hours after surgery.

Secondary bleeding: If bleeding occurs beyond 24 hours within 7-10 days after surgery.

Pain:

Pain will be evaluated by Visual analog score on 1st postoperative day,3rd postoperative day and 7th post operative, visual analog score will be 0 (no pain)1 to 3 (mild),3 to 6(moderate),6 to 9 (severe),10(worst).

24 hours after surgery and beyond 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2025

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

September 19, 2025

First Submitted That Met QC Criteria

November 24, 2025

First Posted (Actual)

December 5, 2025

Study Record Updates

Last Update Posted (Actual)

December 5, 2025

Last Update Submitted That Met QC Criteria

November 24, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • IHHN_IRB_2024_12_021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Tonsillitis

Subscribe